Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials

[1] Van Dieren S(2011)External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes Diabetologia 54 264-270

[2] Peelen LM(2018)Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus: Implications of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study 30-Year Follow-up Endocrinol Metab Clin North Am 47 65-79

[3] Nothlings U(2015)Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry Diabet Care 38 971-978

[4] van der Schouw YT(2015)Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison Diabet Med 32 1036-1050

[5] Rutten GE(2017)Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012 N Engl J Med 376 1419-1429

[6] Spijkerman AM(2019)Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study Diabetologia 62 408-417

[7] Van der AD(2018)Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data Lancet 391 2430-2440

[8] Sluik D(2019)Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures Diabet technol ther 21 336-343

[9] Boeing H(2015)Type 1 diabetes at a crossroads! Diabetes Care 38 968-970

[10] Moons KG(2019)Insulin Therapy in Type 2 Diabetes Am J Ther 322 1312-1313

[1] Van Dieren S(2011)External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes Diabetologia 54 264-270

[2] Peelen LM(2018)Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes Mellitus: Implications of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study 30-Year Follow-up Endocrinol Metab Clin North Am 47 65-79

[3] Nothlings U(2015)Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry Diabet Care 38 971-978

[4] van der Schouw YT(2015)Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison Diabet Med 32 1036-1050

[5] Rutten GE(2017)Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012 N Engl J Med 376 1419-1429

[6] Spijkerman AM(2019)Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study Diabetologia 62 408-417

[7] Van der AD(2018)Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data Lancet 391 2430-2440

[8] Sluik D(2019)Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures Diabet technol ther 21 336-343

[9] Boeing H(2015)Type 1 diabetes at a crossroads! Diabetes Care 38 968-970

[10] Moons KG(2019)Insulin Therapy in Type 2 Diabetes Am J Ther 322 1312-1313